Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 227Carcinoma, Non-Small-Cell Lung 220Prostatic Neoplasms 156Multiple Myeloma 142Neoplasms 134Colorectal Neoplasms 118Leukemia, Myeloid, Acute 109Lung Neoplasms 103Neoplasm Metastasis 99Squamous Cell Carcinoma of Head and Neck 93Carcinoma, Hepatocellular 85Lymphoma 80Melanoma 77Pancreatic Neoplasms 73Triple Negative Breast Neoplasms 72Ovarian Neoplasms 71Sarcoma 66Lymphoma, Large B-Cell, Diffuse 62Recurrence 61Head and Neck Neoplasms 60Carcinoma, Renal Cell 59Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Non-Hodgkin 54Endometrial Neoplasms 54Leukemia, Lymphocytic, Chronic, B-Cell 53Hematologic Neoplasms 53Stomach Neoplasms 52Small Cell Lung Carcinoma 50Urinary Bladder Neoplasms 47

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Amyotrophic Lateral Sclerosis × 90 days × Clear all
NCT07002034 2026-06-03

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡